Pomalidomide D4
| Product Name | Pomalidomide D4 |
|---|---|
| Alternate Names | Pomalidomide Stable Isotopes, Stable Isotopes of Pomalidomide |
| CAT No. | CS-O-13980 |
| CAS No. | 1416575-78-4 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 277.27 g/mol |
| Mol. For. | C₁₃H₇D₄N₃O₄ |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Pomalidomide |
| Purity | 95% |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | O=C(C1=CC=CC(N)=C12)N(C(C([2H])([2H])C([2H])([2H])C3=O)C(N3)=O)C2=O |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Pomalidomide D4 is a deuterated derivative of Pomalidomide, a medication used in the treatment of multiple myeloma. Pomalidomide D4 is a selective inhibitor of the enzyme cereblon, which is involved in the degradation of certain proteins within the body. By inhibiting cereblon, Pomalidomide D4 helps to reduce the levels of abnormal cells in the body, leading to a reduction in the symptoms of multiple myeloma.
Pomalidomide D4 is administered orally, typically in the form of a capsule. The dosage and duration of treatment depend on the individual patient's condition, response to treatment, and other factors that affect treatment efficacy.
In terms of chemical information, Pomalidomide D4 has a molecular formula of C13H3D4N4O3 and a molecular weight of 272.32 g/mol. It is a deuterated derivative of Pomalidomide, with four deuterium atoms replacing hydrogen atoms in the molecule. The deuterium substitution enhances the stability and pharmacokinetic properties of the molecule, leading to improved therapeutic efficacy.
Overall, Pomalidomide D4 is an important medication in the treatment of multiple myeloma, with proven efficacy and a well-established safety profile. It is important to consult with a healthcare professional before starting or changing any medication regimen.
Get an Instant Quote
Related Compounds
Pomalidomide D5 | Pomalidomide-15N-13C5 | Pomalidomide-13C5 |